Manufacturers/Otsuka America Pharmaceutical Inc.

Otsuka America Pharmaceutical Inc.

27 drugs in NADAC|0 Generic,27 Brand

Otsuka America Pharmaceutical Inc. lists 27 NDCs in the CMS NADAC file (0 generic, 27 brand), at an average NADAC of $721.33 per unit, with a week-over-week move of -0.0% across products that moved. The firm's full portfolio, pricing trend are listed below.

Total Drugs

0G / 27B

Avg Price / Unit

$721.3254

$18.62 – $2857.77

Avg 7d Change

-0.01%

Across 21 drugs with changes

7d Activity

8↑13↓6 flat

of 27 total drugs

Portfolio Price Trend

Monthly average NADAC price across all drugs

Keep following this manufacturer

These next-step links connect the manufacturer page to the markets, classes, and trend views most likely to deepen research.

Lead market

ARIPIPRAZOLE market

See the molecule this manufacturer shows up in most often and compare it against competing suppliers.

Lead class

Atypical Antipsychotic therapeutic class

Review the broader class where Otsuka America Pharmaceutical Inc. has the strongest current portfolio footprint.

Trend hub

Portfolio trend view

Jump to the trend hub to compare this manufacturer against the rest of the market on weekly price movement.

Guide

NADAC pricing primer

Use the explainer for context on the benchmark this manufacturer is being compared against.

Frequently Asked Questions

How many drugs does Otsuka America Pharmaceutical Inc. make?

Otsuka America Pharmaceutical Inc. lists 27 NDCs in the CMS NADAC file — 0 generic and 27 brand products.

What is the average price of Otsuka America Pharmaceutical Inc. drugs?

The average NADAC across Otsuka America Pharmaceutical Inc.'s portfolio is $721.3254 per unit, ranging from $18.6155 to $2857.7659.

What types of drugs does Otsuka America Pharmaceutical Inc. make?

Otsuka America Pharmaceutical Inc. makes drugs across 6 FDA pharmacologic classes. The most common by NDC count are Atypical Antipsychotic (19), Vasopressin V2 Receptor Antagonist (1), Antiarrhythmic (1), Cytochrome P450 2D6 Inhibitor (1), Sigma-1 Agonist (1).

Has Otsuka America Pharmaceutical Inc. had any drug recalls?

No FDA enforcement recalls are matched to Otsuka America Pharmaceutical Inc. in the openFDA feed.

How has Otsuka America Pharmaceutical Inc.'s pricing changed recently?

Over the past 7 days, 8 Otsuka America Pharmaceutical Inc. products rose and 13 fell, with a portfolio-wide average change of -0.0%.

Drug Portfolio

27 drugs total, 27 shown

Drug ↕	NDC	Price	7d Change ↕	Class	Market Outlier	Therapeutic Class
ABILIFY MAINTENA ER 400 MG VL aripiprazole	59148024512	$2857.7659 per EA	+0.03%	Brand	High Outlier	—
ABILIFY MAINTENA ER 400 MG VL aripiprazole	59148001971	$2857.7659 per EA	+0.03%	Brand	High Outlier	—
ABILIFY MAINTENA ER 400 MG SYR aripiprazole	59148007280	$2853.2457 per EA	+0.02%	Brand	High Outlier	—
ABILIFY MAINTENA ER 300 MG VL aripiprazole	59148001871	$2141.1481 per EA	+0.10%	Brand	High Outlier	—
ABILIFY MAINTENA ER 300 MG VL aripiprazole	59148023212	$2141.1481 per EA	+0.10%	Brand	High Outlier	—
ABILIFY MAINTENA ER 300 MG SYR aripiprazole	59148004580	$2139.0868 per EA	-0.06%	Brand	High Outlier	—
ABILIFY ASIMTUFII 720 MG/2.4 ML Aripiprazole	59148010280	$1785.2269 per ML	-0.02%	Brand	High Outlier	Atypical Antipsychotic
ABILIFY ASIMTUFII 960 MG/3.2 ML Aripiprazole	59148011480	$1782.9274 per ML	-0.05%	Brand	High Outlier	Atypical Antipsychotic
SAMSCA 15 MG TABLET tolvaptan	59148002050	$300.0891 per EA	—	Brand	High Outlier	Vasopressin V2 Receptor Antagonist
REXULTI 1 MG TABLET brexpiprazole	59148003713	$49.5597 per EA	-0.03%	Brand	—	Atypical Antipsychotic
REXULTI 2 MG TABLET brexpiprazole	59148003813	$49.5252 per EA	-0.02%	Brand	—	Atypical Antipsychotic
REXULTI 3 MG TABLET brexpiprazole	59148003913	$49.5091 per EA	-0.04%	Brand	—	Atypical Antipsychotic
REXULTI 0.25 MG TABLET brexpiprazole	59148003513	$49.4971 per EA	-0.02%	Brand	—	Atypical Antipsychotic
REXULTI 0.5 MG TABLET brexpiprazole	59148003613	$49.4862 per EA	-0.04%	Brand	—	Atypical Antipsychotic
REXULTI 4 MG TABLET brexpiprazole	59148004013	$49.4674 per EA	-0.07%	Brand	—	Atypical Antipsychotic
ABILIFY 20 MG TABLET ARIPIPRAZOLE	59148001035	$40.5602 per EA	—	Brand	High Outlier	Atypical Antipsychotic
ABILIFY 30 MG TABLET ARIPIPRAZOLE	59148001135	$40.4383 per EA	—	Brand	High Outlier	Atypical Antipsychotic
ABILIFY 10 MG TABLET ARIPIPRAZOLE	59148000835	$28.6259 per EA	—	Brand	High Outlier	Atypical Antipsychotic
ABILIFY 15 MG TABLET ARIPIPRAZOLE	59148000935	$28.5496 per EA	—	Brand	High Outlier	Atypical Antipsychotic
ABILIFY 5 MG TABLET ARIPIPRAZOLE	59148000735	$28.4389 per EA	—	Brand	High Outlier	Atypical Antipsychotic
NUEDEXTA 20-10 MG CAPSULE dextromethorphan hydrobromide and quinidine sulfate	59148005316	$26.6353 per EA	+0.13%	Brand	—	Antiarrhythmic, Cytochrome P450 2D6 Inhibitor, Sigma-1 Agonist, Uncompetitive N-methyl-D-aspartate Receptor Antagonist
ABILIFY 20 MG TABLET ARIPIPRAZOLE	59148001013	$26.2504 per EA	-0.03%	Brand	High Outlier	Atypical Antipsychotic
ABILIFY 30 MG TABLET ARIPIPRAZOLE	59148001113	$26.2317 per EA	-0.02%	Brand	High Outlier	Atypical Antipsychotic
ABILIFY 5 MG TABLET ARIPIPRAZOLE	59148000713	$18.6836 per EA	-0.15%	Brand	High Outlier	Atypical Antipsychotic
ABILIFY 2 MG TABLET ARIPIPRAZOLE	59148000613	$18.6555 per EA	+0.01%	Brand	High Outlier	Atypical Antipsychotic
ABILIFY 15 MG TABLET ARIPIPRAZOLE	59148000913	$18.6519 per EA	+0.06%	Brand	High Outlier	Atypical Antipsychotic
ABILIFY 10 MG TABLET ARIPIPRAZOLE	59148000813	$18.6155 per EA	-0.05%	Brand	High Outlier	Atypical Antipsychotic